Partial Purification Of And Attempted Monoclonal Antibody Production Against The Vervet Mokey Hepatic Oestrogen-binding Protein by Bornman, Liza
PART IAL  PU RIF ICATION OF AND A T T E MP TE D  M ONO CLO NAL  
A N T I B O D Y  PRODUCTION A G AIN ST THE VEPV ET MONKEY 
HEPATIC O E ST R O G E N - BI ND I N G  PROT EIN
by
LIZA BORNMAN
A Dissertation submitted to the 
Faculty of Science, University of the Wit.watersrand 
Johannesburg
in fulfilment of the requirements for the Degree of 
Master of Science
PRETORIA 1988
Hepatic cytosols from vervet monkeys (Cercopithecus aethiops pygerythrus) 
were found to contain high affinity oestrogen-binding proteins, In view of 
the interest in the a c M o n  mechanism of steroid hormones in mammalian 
target organs, the vervet monkey was employed as an experimental model in 
t M s  investigation.
Multipoint saturation analyses revealed an equality in the levels of HEBP 
present in male and female animals. An additional high capacity, moderate 
affinity oestrogen-binder has been identified. This binder appears to be 
more prominent in male animals. SDG analyses established the presence of a 
3,8S togc-ther with an 8 ,IS oestrogen-binding component in the hepatic 
cytosol of both sexes. Two oestrogen-binding components (400 000 and 
42 000 d*ltons) were identified in hepatic cytosol with GPC.
The vervet monkey HEBP was partially purified (approximately 7 435-fold) 
by a combination of DES-Agarose and heparir.-Sepharose affinity 
chromatography. This procedure yields an average of 42 pg HEBP from 50 g 
vervet monkey liver. Following affinity chromatography the partially 
purified HEBP migrated as three bands (30 000, 38 000 and 68 000 daltons) 
on an SDS polyacrylamide gel. Isoelectric focussing demonstrated pi values 
of 6*8 and 6,9 for the partially purified HEBP.
Partially purified HEBP was employed to immunize C57 Black/6 mice. The 
serum from the immunized animals contained antibodies against the 
partially purified preparation as determined by ELISA. Splenic lymphocytes 
from the immunized mice were fused with cells of the Sp2 myeloma cell line 
to yield hybridoma cultures, 43* of which produced antibodies against the 
immunized preparation. After clonir.g of the positive polyclonal cell 
culti^es on agar, the selected clones were screened. No antibody activity 
could, however, be detected in the spp"t media of the monoclonal cell 
cultures.
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PREFACE
The mechanism of action of oestrogenic hormones in target tissues has been 
extensively studied during the past two decades. Theories originated from 
the research to define the substantial role of steroid hormone receptors 
1n target tissues. These theories wrre applied in order to aid the 
knowledge of hormone responsive tumours and the subsequent development of 
a sufficient drug for endocrine therapy of e.g. breast cancer patients. 
However, the practical evaluation of the theories postulated was generally 
unsatisfactory. An animal model which resembles that of man closely can 
aid the complete understanding of the in vivo action mechanism of steroid 
hormones in order to overcome the problems experienced in humans.
In view of the interest in the action mechanism of steroid hormones in 
mammalian tarqet organs and the search for a model closer to man, the 
non-human primate, Cercopithecus aethiops pygerythrus, commonly called the 
vervet monkey, was employed as an experimental model in this study. On 
account of the limited availability of uterine tissue the H v e r  of the 
vervet monkey was the target organ used to Investigate the 
oestrogen-binding protein. Because the complete understanding of the ER 
action mechanism 1s hampered by the lack of a pure receptor this study was 
aimed at the development of a purification protocol for the 
oestrogen-binding protein and the production of monoclonal antibodies. The 
latter may provide a powerful tool in revealing the poorly understood 
hormone receptor mechanism.
Chapter 2 will be published as an article 1n the Journal of Steroid 
Biochemistry 1n August 1988 under the title: 'Hepatic estrogen-binding 
proteins in male and femaie vervet monkeys'.
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INTRODUCTION
HISTORY OF STEROID HORMONE RECEPTORS
A correlation between the phase of the menstrual cycle ?nd the 
size of breast tumours as well as a relationship between a" 
increased risk of breast cancer and multi-parity were observed 
as early as 1835 (1 ). In 1889 Schinzinger (2) suggested an 
oophorectomy *o increase the life expectc on in young 
patients, following his observation that the fatality among 
premenopausal breast cancer patients appeared to be higher 
than that recorded for postmenopausal patients. The 
advantageous effect of an oophorectomy in the fight against 
advanced breast cancer was demonstrated by Beatson (3) 1n two 
premenopausal patients in 1396. It became, however, evident 
that a positive response of the patient upon oophorectomy 
could not be guaranteed (4,5). Although irradiation castration
(6 ), rather than surgical oophorectomies was popular at one 
stage, the latter procedure was employed again in the 1950‘s
(7). The isolation of oestrogen from sow ovaries was a great 
step forward in the process of understanding the chemical 
principles of endocrine response (8 ). Charles Huggins made a 
very important contribution with his studies on the effect of 
steroid hormones on cancer. Although, at first his studies 
were focussed on carcinoma of the prostrate (9-11), he 
.•ventually got Involved 1n research on the causes of mammary 
carcinoma (7, 12, 13). He demonstrated that a rel.ipse after an 
oophorectomy can often be overcome by adrenalectomy (7, 12). 
The modern concept of endocrine therapy 1s formulated on 
Hucglns' theory that tumour growth is influenced by the 
hormonal function of the host (13). Luyt and Olivectrona (14) 
reported that hypophysectomy effected a decrease in the 
frequency of metastatic breast cancer, similar to that
achieved by oophorectomy and adrenalectomy. This observation 
was late confirmed by Pearson et -ah (15).
The synthesis of tritium labelled anti-oestrogen (16) and 
oestradiol (17) made 1t possible to illustrate the specific 
accumulation of oestrogens in target tissues. In 1966 Mobbs 
(18) Illustrated the retention of labelled oestradiol in 
dimethylbenzanthracene (DMBA) - induced rat mammary tumours. 
Autonomous tumours did not appear to retain labelled 
oestradiol. With the aid of radioactive labelled hormones, two 
general classes of breast cancer were Identified, those that 
demonstrated uptake of oestradiol and those that showed no 
hormonal uptake (19, 20). Sucrose density gradient 
centrifugation studies done by Toft and Gorski (1966) 
established the presence of a specific, high affinity, low 
capacity oestrogen-binding protein, termed the oestrogen 
receptor (ER) in target tissue cytosol (21). With the aid of 
sucrose density gradients it was possible to determine that 
tumours, responding positively to hormonal therapy, contain 
higher levels of the ER. Hormone-dependent tumours and 
autonomous tumours were therefore determined prior to therapy 
uy this method (19).
In 1968 Jensen et al_. (22) and Gorski et a_L (23) proposed a 
two-step model for the action mechanism of steroid hormones. 
According to their model oestrogen diffuses Into the 
cytoplasm, where it binds to the ER. The resultant complex 1s 
'activated' and translocated to the nucleus where it binds to 
chromatin with a high specificity and affinity and 
subsequently Induces the synthesis of specific m-RNA 
molecules. In confirmatI'"- of this model, Stumpf (24) observed 
the movement of the steroid hormone to the nucleus by 
employing autoradiography.
Different forms of the ER were observed in subsequent studies. 
One form had a relative sedimentation coefficient of 8 S under 
low Ionic strength condition? and which dissociated into 4S 
complexes under high ionic strength conditions (21, 25).
Jensen et jTL (26) reported that a hormone-dependent, 
temperature-induced process appears to transform the cytosolic 
8 S receptor 1 m 3 a 5S form. It was subsequently proved that 
the transformed receptor exhibits a higher affinity for 
polyanions like DNA (27, 28). This transformed receptor was 
therefore termed the 'activated1 form and the foregoing 
process 'activation'.
In 1974 the general agreement between 14 institutions was made 
that patients with receptor-negative cancers would not benefit 
from hormonal manipulations while those with receptor-positive 
cancers would. This conformity was established at a workshop 
held under the protection of the Breast Cancer Task Force.
1.2 MECHANISM OF ACTION 07 THE STEROID HORMONE RECFPTOR
The mechanism of steroid hormone action was Investigated over 
the last three decades by a great number of multifarious 
techniques. Initially, analytical techniques established to 
examine the s'.eroid hormone receptor depended upon cell 
disruption, e-traction of receptors and subsequent binding to 
radioactive labelled hormone. These early techniques have 
provided valuable information, but to clarify the subcellular 
effects and mechanism of hormone action via the receptor 
needed new approaches. More advanced techniques are needed for 
the investigation of subcellular compartmentalliatlon and 
receptor recycling or resynthesis in intact cells. Recently 
developed techniques Include the use of labelled mono- and 
polyclonal antibodies (29-30, cytochalasln B-1nduced 
enucleation (33), radioactive covalent antioestrogen affinity 
labels (34) and autoradiography (35, 36). Investigation of 
steroid * induced events in mutant cell lines that contain 
depressed levels or abnormal receptor (37) or resistent cell 
lines, provides excellent means for revealing some of the more 
complex aspects of the molecular biology of the oestrogen 
receptor and steroid hormone action mechanisms (3(1, 39).
1.2.1 Proposed models for steroid hormone receptors
As stated previously Jensen et a K  (22) and Gorski et aj^ (23) 
proposed the well known 'two-step' model in 1968. It appeared 
as if the receptot was localized in the uterine cytosol (2 1 ). 
By employing cell fractionation and autoradiography it could 
be illustrated that the receptor actually accumulates in the 
nucleus of target cells, following hormone administration 
(22). In this model the ER is described as a cytosolic protein 
that becomes activated after binding to oestrogen. The 
hormone-receptor complex is then translocated to the nucleus 
by a temperature- dependent 'activation' process. A change 1n 
sedimentation coefficient (4S to 5S) 1s established by the 
'activation' process and nuclear receptors can exist only as 
steroid filled entities. With the aid of immunocytochemical 
and enucleation experiments the nuclear localization of the ER 
was observed and as a consequence the nuclear model was 
proposed 129, 33, 40, 41). Receptors not occupied with hormone 
were 1n fact found to be present 1n nuclei of normal (42-44) 
and tumourous oestrogen target tissues (45, 46). These 
unoccupied receptors appear to exhibit characteristics that 
resemble those of the classical nucltar ER (47), except that 
they are unoccupied. The presence of oestrogen receptor 
binding sites in nuclesr preparations has previously been 
reported (48, 49). An equ11ibrlum situation with respect to tne 
Intracellular distribution of intracellular steroid receptors 
has been suggested following autoradiography studies of the 
uptake of trltlated oestradlol by target cells (50). 
Apparently an equilibrium 1s established between the cytoplasm 
and nucleus, which can be shifted 1n favour of the cytoplasm 
during homogenization. Thus the unoccupied receptor which 1s 
quantitively assayed in the cytcsol, obtained by employing 
conventional cytosol preparation techniques, only makes up a 
small fraction of the total receptor contents of the target 
cell (50).
Welshons et a_L (33) employed cytochalasin B-induced 
enucleation to obtain cytoplast and nucleoplast fractions from 
receptor-containing GH^ cells, derived from rat pituitary 
tumours. This technique appears to overcome the problem of 
receptor solubilization during the preparation of cell 
nuclei. The results obtained during this study Indicated 
clearly that the receptor is localized in the target cell 
nucleus. Very low levels of oestrogen-binding activity could 
be traced in the cytoplasts. These findings led to the 
proposal of the nuclear model in which both oestrogen-binding 
and activation occur within the target cell nucleus. The 
biological relevance of the cytosolic ER and Its so-called 
nuclear translocation can be seriously questioned following 
the pioneering work of Welshons and his group. The cytosolic 
ER can well be seen as an extraction artifact. Furthermore the 
cytosolic receptor recovered in the low salt fraction of a 
tissue homogenate is thought to be receptor that was loosely 
bound to nuclear components and the translocation artifact is 
attributed to Increased nucleotrophy of the ER-oestrogen 
complex.
It was generally believed that antibodies to the ER might 
reveal some of the most controversial aspects concerning the 
mechanism of action of the ER. During immunohistochemical 
studies it became quite evident that the unliganded ER is 
mainly localized in the nucleus (29). The group of King and 
Greene used monoclonal antibodies against the ER to provide 
information about inter- and Intracellular receptor 
distribution 1n different tlsues by an Indirect 
immunoperoxldase technique (30-32). Regardless of hormonal 
status, the specific immunoperoxldase staining for ti.e ER was 
observed 1n the nuclei of all stained cells. Little, or no 
cytoplasmic staining could be detected 1n any of the 
preparations even when tissues were deprived from exogenous 
oestrogens. Following j_n vi_vo or in vitro treatment of the 
cells, the staining of nuclei appeared to be even more 
Intense, yet, no cytoplasmic staining could be observed. These
results correlated with the enucleation experiments of 
Welshons et aj^ (33), in which unoccupied ER was almost 
exclusively partitioned into the nucleoplast fraction.
There are, however, some doubts about the immuriocytochemical 
and enucleation evidence for the nuclear localized ER. It has 
previously been shown that the primary anti-ER monoclonal 
antibodies of King and Greene are incompetent in recognizing 
the ER (51, 52). The technique of enucleation is powerful in 
the study of cytoplasmic/nuclear interaction in cell fusion 
experiments but its usefulness to localize the ER is uncertain 
(53). It should also be noted that 1n contrast to the ER, 
immunoreactive glucocorticoid and progesterone receptors have 
been observed both in the cytoplasm and the nuclei of target 
cells (54-56).
Even though some controversy still remains on the issue of the 
intracellular localization of the steroid hormone receptor, in 
the final analysis the steroid receptor complex is still a 
nuclear regulatory element wherever the receptor resides in 
the target cell. Until unequivocal evidence concerning the 
localization of the receptor is produced 1t may be unwise to 
discard any of the above-mentioned models.
1.2.2 Binding mechanism of steroid hormone receptors
It is generally agreed that steroids enter cells by diffusion. 
With double-isotope steady-state studies 1t was revealed that 
the accumulation of steroids was the same in t?r j I as well as 
non-tarqet tissue, at a concentration corresponding to the 
steroid concentration, indicating a diffusion mechanism (57). 
However, the presence of specific binding sites on the plasma 
membrane of target cells can not be ruled out. In 1974 Szego 
(58) proposed a plasma membrane model for steroid action. The 
model comprises the following steps: Following the binding of 
oestrogen to a plasma membrane-associated ER the receptor 
complex is Internalized by a process of pinocytosls and then 
transferred to the nucleus by circulating lysosomes. Zanker
et £lL (59) reported on a putative plasma membrane Integrated 
ER with a modulator function. The properties of this high 
affinity (K^ * 6,4 x 10 M) binding protein corresponds to a 
large extent to that of the cytosolic receptor.
The Kd value of a receptor (reciprocal of tne association 
constant, K ' obtained from a Scatchard plot (60), is
G
approximately equal to the concentration of free steroid at 
which half of the receptors are saturated. A specific hormone 
may bind to more than one high-affinity receptor and various 
hormones may interact with one class of receptor. Baulleu (61) 
observed that oestradiol interacts with both the androgen and 
oestrogen receptors at values of 3 nM an 0,1 nM
respectively. However, aftei diffusion or specific 
internalization of the hormone into a target cell 1t binds to 
specific or distinct high-affinity receptors or to the more 
abundant low-affinity binding sites.
The biochemical-biophysical properties of the ER following 
internalization is still unclear. A variety of factors, such 
as Ionic strength, temperature, molybdate and enzyme 
inhibitors have an influence on the molecular form of the ER 
and may even give rise to multiple forms. The various forms 
observed under these conditions may, however, not necessarily 
be identical to the endogenous receptor (61, 62). Following 
the binding of oestrogen to the ER, the ER-oestrogen complex 
undergoes transformation and activation. Multiple forms of the 
ER have previously been ascribed to the degeneration of the 
native receptor. Sherman e_t £1^ (63) have demonstrated that 
'meroreceptors1 are products resuli 'g from endogenous 
protease activity, which exhibit high aiMnity, low capacity 
hormone binding properties. Several other studies suggest that 
degradation of native receptors by proteolytic and other 
factors may be responsible for the generation of multiple 
forms of the ER (64). Hendry and Danzo (65) characterized a 
steroid receptor-active protease from the rabbit epididymis. 
This leupeptin-sensitlve protease apparently alters the
sedimentation coefficient of the cytosolic steroid receptors 
by clipping off a portion of the ER necessary for nucleotide 
binding. In order to investigate native steroid hormone 
receptors and other protective factors, protease Inhibitors 
are generally included during purification and 
characterization (6 6 ).
Receptor activation (the capacity of the oestrogen-receptor 
complex to bind to nucleic acid) precedes transformation 
(4S to 5S dimerization) and can be measured by the 
dissociation kinetics of a hormone from the receptor. The 
dissociation of oestradiol from the receptor appears to be a 
biphasic process (67). Muller £t a_K (6 8 ) proposed that the 4S 
receptor monomers exist in two conformational states. Changes 
in conformation occur after oestradiol binding to the low 
affinity state and result in stronger interactions between the 
steroid and the amino acid residues of the oestrogen-binding 
domain (69). Subsequently the rate of oestradiol dissociation 
decreases. The equilibrium is shifted from a lower-affinity 
state to a high-affinity, activated, slow dissociating phase 
(67).
Steroid hormone receptors are a group of gene regulatory 
proteins. Hormone ligands trigger their biological activity 
and they interact with hormone responsive elements 1n the DNA. 
Steroid hormone receptors are constructed in domains linked ty 
hinge regions which are rather sensitive to proteolytic 
degradation (70). Gehring (70) proposed a steroid hormone 
receptor model that consisted of three distinct domains: a 
steroid and a DNA binding domain together with a domain 
exerting a modulating effect on the receptor's interaction 
with DNA. It is suggested that the latter modulates the extent 
of hormonal responsiveness by facilitating tne discrimination 
between specific and unspecific regions on the DNA. The DNA 
binding domain 1 s a region in the middle of the polypeptide 
chain, rich in basic amino acids and cysteines. The hormone
binding domain and modulator domain are located in the 
carboxy- ana amino-terminal regions respectively.
The primary structures of most types of steroid receptors have 
been derived from the respective nucleotide sequences. Amino 
acid sequences of the complete human and chicken ERs (71-73), 
human, mouse and rat glucocorticoid receptors (74-76) and 
rabbit progesterone receptor (PR) (77) as well as partial 
sequences of the chicken PR (78, 79) are already known. 
Although the sequences differ significantly in length, there 
exists a noticeable homology between these different 
receptors. The central DNA binding domain appears to be the 
most highly conserved. The homology between hormone binding 
domains is very high for receptors of the same hormone or 
structurally related ligands species. However, the homology 
between the hormone-binding domains of the steroid and thyroid 
receptors 1s much lower. The highest degree of diversity 1n 
length and sequence is present Detween the modulator domains 
(amino-terminal). Gehring (70) mentioned the striking 
conservation of cysteines and several basic and hydrophobic 
residues 1n the DNA binding domain and illustrated the 
Importance of this domain for the steroid hormone mechanism of 
action. It has been suggested that the DNA binding domain of 
steroid hormone receptors contain DNA binding fingers, that 1s 
stretches of amino acid residues which include pairs of 
cysteines and histidines forming ^inger-like structures which 
make contact with DNA (80). Experiments employing human EK 
cDNA Illustrated that a 252 amino acid sequence 1s responsible 
for oestradiol binding (81). Trimmed polypeptides containing 
only the hormone binding domain are adequate for hormone 
binding (81, 82). Deletion studies revealed that although 
small truncations of the carboxy-terminal residues of the GR 
failed to produce a biological response, longer deletions of 
the carboxy-terminal or truncation of the amino-terminal led 
to transcriptional activation even without hormone binding. 
From these re.'jits it was suggested that the hormone binding 
domain represses receptor function in the unllganded state. It
seems that steroid binding unmasks the DNA binding domain by 
structural changes with subsequent transcriptional activation. 
This was also observbed with the ERs (70). Specificity for 
gene activation resides within the DNA binding domain because 
one specific hormone binding domain can interact with that of 
another.
The 'putative acceptor' and 'effector' sites on the 
chromosomes are sites of oestrogen-receptor complex binding 
and gene expression (23). Selective binding of steroid hormone 
receptors to specific DNA sequences within or near 
hormone-regulated genes has previously been demonstrated 
(83, 84). With the recognition of DNA ‘.equences within or near 
normone-regulated genes 1t was suggested that steroid 
receptors may modulate transcription. Oestrogen-receptor 
complexes bind with high affinity to a specific structure of 
the DNA and non-histone protein (85). Low affinity binding 
sites are also present 1n large numbers on chromatin (8 6 ). 
Clark et V L  (87) described a type II site which is not 
translocated to the nucleus, is more abundant and remains 
elevated for longer periods than the sites (type I) which are 
translocated from the cytoplasm.
Processing, with a 70% loss of bound nuclear receptor sites 
over a few hours has been proposed (8 8 ). However, Siebert and 
Lippman (89) stated that processing does not entail 
disappearance of the receptor complex but a modification 
process. The step following translocation and nuclear binding 
(activation) is thought to be dephosphorylation by a nuclear 
phosphatase (90). In agreement, Aurlcchio (91, 92) 
hypothesized that inactive receptors are reactivated through 
phosphorylation by an ATP-dependent enzyme. Therefore 
dephosphorylation and rephosphorylation in the nucleus and 
cytoplasm respectively assure receptor circulation.
STEROID RECEPTORS IN NORMAL AND PATHOLOGICAL HEPATIC TISSUE
Although the liver is not clasically regarded as an 
oestrogen-dependant organ, like the breast and uterus, it is 
an oestrogen-responsive organ (93, 94). Several studies during 
the past decade have demonstrated specific receptors for 
oestrogens in the livers of various mammals such as the rat 
(95, 96), raubit (97) and green monkey (96). Binding of 
oestradiol to these receptors is of high affinity, low 
capacity, saturable and specific. The hepatic oestrogen- 
receptor complexes undergo nuclear t r a n s l a t i o n  in a cell- 
free system (98). This correlates with oestrogen 
responsiveness of the liver which synthesizes a variety of 
plasma transport proteins (93, 99-101).
Oestrogen-recsptors have been demonstrated to be present 1n 
the livers of both male and female mammals. In 1979 Aten 
et al. (102) and Eisenfeld and Aten (103) observed the 
presence of hepatic oestradiol binding sites in both sexes of 
the green monkey, the rat and the rabbit. Aten et al^ (102) 
reoorted a similarity in the binding sites of both sexes 
except for the two-to-three-fold higher valuer> in the affinity 
and capacity of the oestradiol blnuing sites in female liver 
cytosol. In contrast to the adult male green monkey liver 
cytosol, Eisenfeld and Aten (103) reported on an additional 
set of oestradiol binding sites 1n the adult male rat liver 
cytosol. These sites were present at higher concentrations 
(500-to 1000-fold) than that of the putative oestrogen 
receptor and displayed a lower affinity towards oestradiol. 
The concentration of this binder was reportedly 200-fold 
higher in the adult male liver rytosol than 1n the matur; 
female or immature male rat liver cytosol. Powell-Jones et al. 
(104) reported that ERs are present 1n equal levels in male 
and female liver cytosol. The receptors in both sexes 
demonstrated similar steroid specificities and affinities. 
However, an additional binding protein was Identified 1n 
hepatic cytosol of mature male rats. This protein which 1s
either absent or present In small amounts 1n mature female and 
•^mature male and female animals, exhibits a high binding 
capacity for oestrogens and androgens (10<). It is designated 
a male-specific oestrogen-binding protein (male-SBP or MEB) 
(104, 105) or the unusual oestrogen-binding protein (UEBP) 
(106). This protein is distinctly different from the ER 
because it demonstrated a high binding capacity, a 3 • 45 
sedimentation coefficient on sucrose density gradients (104) 
and androgen dependency. Various groups have suggested that 
the male specific binding protein functions as a scavenger to 
bind excess oestrogen or oestrogenic metabolites and therefore 
protects the male hepatocyte from the unwanted effects of 
excess oestrogen (105, 107). During surgical manipulations it 
was illustrated that the sex differences with respect to the 
levels of 4S binding in tne liver are controlled by the 
pituitary (104). Following the examination of the role played 
by steroid; and the hypophysis in the regulation of the UEBP, 
Smirnova et a_L (106) concluded that oestrogen-androgen 
regulation of the UEBP level led to the maintenance of sex 
differences 1n the UEBP content. Lax et a h  (108) determined 
the Influence of different factors on the hepatic nuclear ER 
concentration in the rat. Age - but no sex-dependent 
variations in the course of life 1n the nuclei ER 
concentration of vehicle-treated rats were observed.
The hepatic oestrogen receptor appears to be under endocrine 
contrcl. Previous investigations have shown that the pituitary 
regulates the expression of hepatic ER. Hypophysectomy 
virtually eliminates receptor concentrations in both the male 
and the female (104, 109, 110). In addition sex differences 
are eradicated as far as male-SBP levels are concerned in 
hypophysectomized rats (111). Ovariectomy results in an 
increased receptor level probably as a result of the 
elimination of endogenous ligands. Smirnova et a1_. (106) 
investigated the effect of sex steroids and the hypophysis on 
the regulation of the UEBP. They concluded that 
oestrogen-androgen controlling of the UEBP contents led to the
maintenance of sex differences in the UEBP levels. Rumbaugh 
et a K  (1 1 2 ) performed a study to characterize the complexity 
of the hormonal regulation of the two classes of 
oestrogen-binding proteins known to exist 1n the liver. They 
found that hypophysectomy on rats at any age, eliminates sex 
differences with respect to thr levels of high capacity, low 
affinity oestrogen-binding sitf>s. Moreover, hypophysectomy at 
any age removed the hepatic ER completely. It was suggested 
that the two classes of hepatic oestrogen-binding protein are 
under different forms of pituitary control. Their study 
illustrates multitudinous regulation and age dependence of the 
hepatic oestrogen-binding protein by the pituitary. The 
endocrine regulation of the synthesis of ER in the 
regenerating rat liver was previously Investigated (113). Tnis 
Investigation was carried out under vivo conditions by 
employing partial hepatectomy, castration and hypophysectomy. 
Multi-endocrine control by the gonads and pituitary of the ER 
was indicated by the results obtained, 'lowever, no indication 
of an independent direct Influence of oestrogens on ER 
synthesis 1n the rat liver was observed. In 1981 Powell-Jones 
et al. (114) studied the ontogeny of the two oestrogen-binding 
sites 1n rat liver cytosol, by determining the effect of 
gonadectomy on the levels of these sites. It became clear that 
testicular androgens program the sexual differentiation of 
high capacity oestrogen-binding sites at birth. By employing 
isoelectric focussing 1n polyacrylamide gels Norstedt et a_L 
(115) previously measured ER levels in the liver of 
ovarlectomlzed female rats. A reduction 1n hepatic receptor 
levels was identified for hypophysectomized (10%) and 
adrenalectomlzed (42") rats. Thus 1t can be concluded that the 
rat hepatic ER 1s under multi hormonal control.
Since the identification of ERs In a variety of animal and 
human tissues, comparative studies of the properties of these 
ERs have been launched (116). Tong et al. (117) compare ne 
physical and chemical properties of the ER proteins from the 
liver, kidney and uterus of the female rabbit under Identical
exnerimental conditions. The ERs were identical in terms of 
p!.-activity profiles, dependence on incubation temperature, 
sensitivity to sulfhydryl reagents and steroid specificity. In 
all three tissues oestradiol binding was saturable with a 
dissociation constant of 4 x 10 M. However, heparln- 
Sepharose chromatographic behaviour was different for the 
three ERs. Moreover, the liver and kidney ERs exist as 3-4S 
entities in low ar.d high ionic strength conditions to the 7-8S 
and 4-5S sedimentation coefficients of the uterine receptor in 
low and high ionic strength media respectively. A combination 
of liver and uterine cytosol fractions resulted in a 3-4S 
receptor in low ionic strength conditions. Some researchers 
have, however, reported that the liver ER appears to be very 
similar to at. other steroid receptors so far described (118): 
a large cytoplasmic form, stablized by molybdate which is 
transformed to a smaller form.
Following the original discovery of oestrogen receptor in 
liver (96, 102, 103, 105, 1 19, 120) many attempts have been 
made to define a possible role for steroid hormones, 
particularly oestrogens, in the pathogenesis of various 
hepatic diseases. This 1s especially true for hepatic adenoma 
(HA) (121), focal nodular hyperplasia (FNH) (122), hepatoma 
and angiosarcoma (123, 124).
Porter et al. (125) demonstrated, with the aid of binding 
studies that cytosolic and nuclear ERs are present in the case 
of HA and Fi'IH. They observed higher levels of the ER 1n 
neoplastic tissues than in normal tissue and therefore 
suggested that a greater hormone responsiveness may be 
possible in neoplastic U v e r  tissue. The androgen and ER have 
been examined by Ohnishi et aj_. (126). They reported the 
presence of ER in the cytosol in one out of seven cancerous 
tissues. In three out of seven non-cancerous tissues the ER 
was present in the cytosol ard/or nucleosol. The amount of ER 
in the one positively assayed cancerous tissue was 
approximately double that of the surrounding non-cancerous
tissues. Although they didn't examine the nucleosol of 
cancerous tissue for ER, they suggested a suppression of the 
ER, compared to the androgen receptor, in association with 
maliynant transformation. Molteni et ah_ (127), Friedman 
et a h  (128) and Iqbal et al_. (129) illustrated that the ER is 
present in the cytosol of human hepatocellular carcinoma (HCC.) 
at levels similar to that in normal liver tissue. The ER 
levels in the HCC and surrounding tissue have also been 
assayed by Nagasue et a h  (130). The ER was detected in 40% of 
the HCC and 46% of cirrhotic livers. Two livers with chronic 
hepatitis were ER-negatlve. They speculated upon the 
possibility of employing hormone therapy f the treatment of 
naturally occurring HCC. Francavilla et (124) compared the 
oestrugen-binding activity in Moris hepatoma 7777 with normal 
rat Hver. A great decrease in the cytosolic oestrogen-binding 
activity of the hepatoma compared to that in normal hepatic 
cytosol was reported. Furthermore, the ER has been detected in 
human adenoma at much lower levels than in normal H v e r  tissue 
(131). Mays and Christopherson (132) found insignificant 
cytosolic ER levels in five out of six HAs resected from women 
exposed to oral contraceptive steroids (OCS). The one 
ER-posit1ve HA contained less ER than normal liver tissue. 
Friedman e_t aj_. (128) analyzed five livers with HCC for ER. 
Higher ER levels were observed in the adjacent normal tissue 
than 1n the HCC tissue. However, no nuclear ER levels were 
reported in either of these studies.
The possibility exists that oestrogens may contribute to the 
formation of liver tumours through oestrogen receptor-mediated 
mechanisms. Some authors have suggested that oertrogens are 
carcinogenic (133, 134). Others suggested that oestrogens 
promote carcinogenic effects of procarcinogens but that they 
are not intrinsically carcinogenic (135-137). Wanless and 
Medline (138) showed that oestrogens promote hepatic neoplasm 
development by a mechanism that increases the mitogenlc 
activity of the hepatocyte. The dose: of oestrogen employed ir
this study were much greater than those generally used in 
clinical treatments.
Exogenous oestrogens may also play a role in the development 
of benign (138) and malignant (137) hepatic tumours. Evidence 
exists that oral contraceptive steroids (OCS) induce benign 
(139) and prcbably malignant (140) tumours of the liver. 
However, the role of OC in HCC has recently been questioned 
(141). Administration of norethynodrel and norethisterone, 
alone or in combination with mestranol, a synthetic oestrogen, 
leads to an increase in benign and in some cases malignant 
hepatic neoplasms in male rats. An increase 1n HCC 1n female 
rats has been observed following administration of megestrol 
and/or ethinyloestradiol. 0 »strogens are suggested to be 
promoters of U v e r  cell gr>>lh (142). Mishkin et (143) 
questioned the biological importance of oestrogens during 
malignant transformation of hepatic tumours. They demonstrated 
a setback of acetylaminofluorine-induced hepatic hypertrophy, 
nodular proliferation and malignant transformation with 
oestrogen and tamoxifen administration. The inhibitors of 
hepatic neoplasia by oestrogens has also been demonstrated 
(144) 1n contrast to reports that illustrate oestrogens as 
Initiators of neoplastic growth (145). Regression of 
carcinogen-induced hyperplastic nodules and suppression of 
malignant transformation of tumours by high doses of oestrogen 
or tamoxifen have been reported (143). At this stage 1t 1s 
uncertain as to which factors control receptor levels, and 
what the role of the ER 1s 1n the disease process. Clearly, 
much more needs to be learned about the influence of 
oestrogens and their receptors 1n the pathogenesis and 
promotion of liver diseases.
CHAPTER 2
HEPATIC OESTROGEN-BINDING PROTEINS IN MALE AND FEMALE VERVET MONKEYS
2.1 INTRODUCTION
The presence of high affinity oestrogen-binding sites 1n 
hepatic cytosols of a number of species, including the green 
monkey (Cercopithecus aethiops) has been identified (102, 103, 
1C4, 147). Hepatic oestrogen receptors have been found to be 
present in the liver cytosols of both sexes of the species 
investigated (102, 103, 120). Recently it was illustrated that 
two distinct classes of oestrogen-binding proteins exist 1n 
hepatic cytosols of rats (104, 106, 146, 149). The one class 
displayed a high affinity for oestrogen and had a relative 
sedimentation of 8 S, while the other binder exhibited an 
affinity of approximately an order lower with a relative 
sedimentation of 4S (104, 105). The 4S binder was reported to 
be androgen-dependent (104, 105). It has been suggested that 
the function of this high capacity, low affinity 
oestrogen-binding component was to regulate the availability 
of oestrogen for its receptor (104, 105). Oestrogen receptors 
are reportedly present in equal levels in both male and female 
livers (104, 150). The so-called male-specific oestrogen- 
binding protein appears to be regulated by pituitary-dependent 
sexual differentiation at puberty. This apparently leads to 
the phenomenon that males contain higher levels of the 4S 
binder than females (104). In spite of all these speculations 
there is still no clear understanding of the exact biochemical 
function of the oestrogen-binding proteins In the mammalian 
Uver.
The vervet monkey is employed as an experimental model 1n 
order to investigate the mechanism of action of sterlod 
hormones in mammalian target organs. The distribution and
molecular properties of oestrogen and progesterone receptors 
in the uterus of the same model have previously been reported 
(151).
In this chapter the presence and levels of oestrogen-binding 
proteins in the livers of both male and female vervet monkeys 
are described. Some of the molecular prooerties of the crude 
cytosolic HEBPs are diccussed.
2.2 MATERIALS AND METHODS
2.2.1 Reagents
17s [ H] - Oestradiol (168 Ci/mmol) was obtained from 
Amersham, England. [ ^ C ]  - Methylated albumin (0,02 mC1/mg) 
was purchased from New England Nuclear. Radioligands were 
Initially checked for radiochemical purity on reverse phase 
high performance liquid chromatography (HPLC). Oestrone (E^), 
oestradiol (E^), oestrlol (E^), testosterone (T), dehydro* 
testosterone (DHT), dehydroepiandrosterone (DHE*>, diethyl* 
stilboestrol (DES), norethindrone (NE), hydrocortisone (HC) 
and ethinyloestradiol (EE^) were obtained from Sigma Chemical 
Company. Progestero e (P) and promogestone (R5020) were 
purchased from New England Nuclear. Tris(hydroxymethyl)* 
aminomethane (Tr1s), ethylenediaminotetraacetate (EDTA), 
glycerol, sucrose, activated charcoal and sodium azide were 
obtained from Merck Chemicals. Dithiothreitol and gelatine 
(Carrageenan, Type 1) were bought from Sigma Chemical Company, 
while Dextran T 70 was purchased from Pharmacia. Ready-Solv HP 
scintillation cocktail was obtained from Beckman Instruments.
A Beckman LS 5800 counter was used for scintillation counting 
at an efficiency of 34-40%.
2.2.2 Buffers
TEDAG buffer: Tris-HCl (10 mM), EDTA (1,5 mM), dithiothreitol 
(1 mM), sodium azide (1 mM), glycerol (10% m/v), pH 7,4 (4°C). 
TEDAGM buffer: Prepared as TEDAG buffer with the addition of 
sodium moiybdate (10 mM).
PEOGP (0,15): Sodium phosphate (25 mM), EDTA (1,5 mM), 
dithiothreitol (1 mM), glycerol (10% m/v), potassium chloride 
(0,15 M), pH 7,4.
PEDGP (0,40): Prepared as PEDGP (0,15) with a final potassium 
chloride concentration of 0,40 M.
This suspension consisted of pre-washed, activated charcoal 
(0,5% m/v), gelatine (Carrageenan Type 1) (0,1% m/v), dextran 
T 70 (0,5% m^v) prrpared in TEDAG or TEDAGM buffer.
Concentration ranges (0,25 - 3 nM) of tritiated oestradiol 
were prepared in TEDAG or TEDAGM in the presence or absence of 
a 5 000-fold excess of unlabelled hydrocortisone. Identical 
concentration ranges for the determination of non-specific 
binding were prepared in the presence of a 1 0 0 0 -fold excess 
of unlabelled DES. Competing ligands (E^, E^, E^, T, DHT, 
DHEA, DES, NE.HC, EE^♦ P and R5020) were prepared 1n TEDAG 
(0,675 nM - 10 nM) from stock solutions (1 mM) in ethanol.
Vervet monkey livers, obtained from the National Institute of 
Virology, Edenvale, South Africa, were immediately placed on 
1ce, before transportation to the laboratory. The livers were 
trimmed of fat and connective tissue and rinsed once in 1ce
2.2.3 Dextran coated charcoal
2.2.4 Ligands and competitors
2.2.5 Liver tissue
cold homogenization buffer (TEDAG or TEDAGM). Liver samples 
not immediately used were quick-frozen with dry 1ce and stored 
at -70°C until use.
2.2.6 Preparation of cytosol
Fresh or frozen liver tissue, kept on crushed 1ce, was cut 
into thin slices with a scalpel. The slices were then 
suspended 1n five volumes of pre-cooled TEDAG or TEDAGM per 
unit mass of tissue and homogenized (TP 10 Ultra Turrax, Janke 
and Kunkel). Cytosol was obtained by centrifugation of the 
tissue homogenates at 105 "*00 g for 30 m1n. and collecting the 
clear supernatant. All steps were carried out at 4°C.
2.2.7 Protein determination
Protein concentrations of cytosol were determined by the 
method of Rradford (152) by employing the Bio-rad standard 
assay procedure with bovine serum albumin as standard. Samples 
and standards were analysed in duplicate simultaneously. In 
Figure 2.1 the standard curve for the B1o-rad standard assay 
procedure, using bovine serum albumin as standard, is 
depicted.
2.2.8 Oestrogen receptor assay
Aliquots of hepatic cytosol (100 m*) were Incubated with 
varying concentrations of trltiated oestradiol for 16 h at 
4°C. Non-specific binding was assayed in the same way except 
that the tritiated ligand solutions contained a 1 0 0 0 -fold 
excess of unlabelled DES. Unbound steroid was removed with the 
addition of 500 dextran coated charcoa1 (DCC). The 
suspension was left on ice for 10 min. and centrifuged at
2 000 g for 15 min. Aliquots (0,5 m«) of the supernatant were 
counted 1n a Beckman LS 5800 counter, following the addition 
of scintillation cocktail (4 mf).
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FIGURE 2.1
A typical standard curve for the determination of microgram quantities of 
protein. The Bio-rad standard assay procedure was employed as outlined in 
section 2.2.7. Bovine serum albumin (25-140 pg) was used as protein 
standard. The 99% confidence limits are indicated by the dotted lines.
2.2.9 Ligand specificity of the HEBP
Aliquots of hepatic cytosol (100 p O  prepared in the absence 
of molybdate (TEDAG) were incubated with 50 \i( of trltiated 
oestradiol (8 nM final concentration) in the presence of 50 p« 
of Increasing concentrations of various competitors (Ej, E^, 
E3 , T, DHT, DHEA, DES, NE. HC, EEg, P and R5020) for 16 h at 
4°C. Reactions were terminated by the addition of DCC (500 \t() 
and bound, tritiated oestradiol was determined as described 1n 
Section 2.2.8.
2.2.10 Oestradiol binding in U v e r  cytosol prepared from tissue o.” 
different areas 1n the same U v e r
Liver tissue dissected from three locations in the liver 
(lobe 1, 2, and 3) was used for the preparation of cytosol 1n 
TEDAG at a protein concentration of 5 mg/mf. Binding assays 
were performed as described 1n Section 2.2.8 with trltiated 
o?<trad1o1 concentration ranges (0,25-3 nM) prepared in TEDAG 
1n the presence and absence of a 1 0 0 0 -fold excess of 
unlabelled DES.
2.2.11 Oestradiol binding 1n liver cytosol prepared at different 
protein concentration1;.
Hepatic cytosol was prepared in TEDAG at three different 
protein concentrations (5, 10 and 18 mg/m?). Binding assays 
were performed as described 1n Section 2.2.8 with trltiated 
oestradiol concentration range. (0,25-3 nM) prepared in TEDAG 
1n the presence and absence of a 1 0 0 0 -fold excess of 
unlabelled DES.
2.2.12 Oestradiol bln 11ng 1n cytosol prepared from liver obtained 
from male and female vervet monkeys.
Liver tissue dissected from the U v e r  obtained from male and 
female vervet monkeys was used for the preparation of cytosol
in TEDAG at a protein concentration of 5 mg/m€. binding assays 
were performed as described 1n Section 2.2.8 with tritiated 
oestradiol concentration ranges (0,78 - 50 nM) prepared in 
TEDAG 1n the presence and absence of a 1 000-fold excess of 
unlabel led DES.
2.2.13 Oestradiol binding in liver cytosol in the presence or absence 
of sodium molybdate and hydrocortisone.
Hepatic cytosol was prepared 1n TEDAG or TEDAGM. Binding 
assays were performed as described in Section 2.2.8 with 
tritiated oestradiol concentration ranges (0,25-3 nM) prepared 
in the presence or absence of sodium molybdate and 
hydrocortisone respectively. Non-specific binding was 
determined 1n the presence of a 1 0 0 0 -fold excess of 
unlabel led DES.
2.2.14 Sucrose density gradient analysis
Tritiated oestradiol (20 nM) was prepared 1n TEDAG or TEDAGM 
1n the presence or absence of a 5 000-fold excess of 
unlahelled hydrocortisone. Sucrose density gradients (SDG) 
(10-35%) were prepared 1n TEDAG. Linearity of the SDG were 
■nonltored by refractometry (Figure 2.2). Unlabelled marker 
proteins myoglobin (2,OS), ovalbumin (3,6S), bovine serum 
albumin (4,6S) and aldolase (7.35S) were employed for the 
calibration of the gradients (Figure 2.3). Aliquots (200 p?) 
of the marker proteins were layered separately onto gradients 
(1 mg). The duplicate gradients of each marker protein were 
run and subsequently fractionated and scanned spectrophoto- 
metrlcally at 280 nm. Cytosol was incubated with tritiated 
oestradiol at a final concentration of 10 nM with and without 
a 1 000-fold excess of unlabelled DES for 16 h at 4°C. Unbound 
ligand was removed with DCC treatment. Aliquots of the 
cytosols (200 pf) were layered on top of the gradients and 
centrifuged at 520 000 g for 2 h at 4"C. Protein concentration 
of cytosols was approximately 10 mg/m«. Gradients were
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